The expression of Mcl-1 in human cervical cancer and its clinical significance

Medical Oncology

Volumn 29, Issue 3, 2012, Pages 1985-1991

  Zhang, Ting ^a   Zhao, Chun ^b   Luo, Liang ^c,d   Zhao, Hua ^a   Cheng, Jing ^a   Xu, Fei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^d WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

Cervical cancer; Ki 67; Mcl 1; Prognosis

Indexed keywords

BIOLOGICAL MARKER; KI 67 ANTIGEN; PROTEIN MCL 1;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; NEOPLASM GRADING; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84872822854     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-0005-y     Document Type: Article

References (22)

1. Hu X, Schwarz JK, Lewis JS Jr, et al. A microRNA expression signature for cervical cancer prognosis. Cancer Res. 2010;70:1441-8.
2. O'Meara AT. Present standards for cervical cancer screening. Curr Opin Oncol. 2002;14:505-11.
3. Martin CM, Astbury K, O'Leary JJ. Molecular profiling of cervical neoplasia. Expert Rev Mol Diagn. 2006;6:217-29.
4. Clohessy JG, Zhuang J, de Boer J, et al. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis. J Biol Chem. 2006;281:5750-9.
5. Cuconati A, Mukherjee C, Perez D, et al. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev. 2003;17:2922-32.
6. Shimazu T, Degenhardt K, Nur-E-Kamal A, et al. NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition. Genes Dev. 2007;21:929-41.
7. Sieghart W, Losert D, Strommer S, et al. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. J Hepatol. 2006;44:151-7.
8. Khoury JD, Medeiros LJ, Rassidakis GZ, et al. Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state and p53 overexpression. J Pathol. 2003;199:90-7.
9. Inagawa S, Itabashi M, Adachi S, et al. Expression and prognostic roles of beta catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival. Clin Cancer Res. 2002;8:450-6.
10. Cotran RS, Kumar V, Collins T. Cellular injury and cell death. In: Robbins pathologic basis of disease. 7th edn. Philadelphia: Elsevier Saunders; 2004.
11. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-6.
12. Akgul C, Turner PC, White MR, et al. Functional analysis of the human MCL-1 gene. Cell Mol Life Sci. 2000;57:684-91.
13. Schubert KM, Duronio V. Distinct roles for extracellular-signal regulated protein kinase (ERK) mitogen-activated protein kinases and phosphatidylinositol 3-kinase in the regulation of Mcl-1 synthesis. Biochem J. 2001;356:473-80.
14. Leuenroth SJ, Grutkoski PS, Ayala A, et al. The loss of Mcl-1 expression in human polymorphonuclear leukocytes promotes apoptosis. J Leukoc Biol. 2000;68:158-66.
15. Willis SN, Chen L, Dewson G, et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005;19:1294-305.
16. Cho-Vega JH, Rassidakis GZ, Admirand JH, et al. MCL-1 expression in B-cell non-Hodgkin's lymphomas. Hum Pathol. 2004;35:1095-100.
17. Allen TD, Zhu CQ, Jones KD, et al. Interaction between MYC and MCL1 in the genesis and outcome of non-small-cell lung cancer. Cancer Res. 2011;71:2212-21.
18. Schulze-Bergkamen H, Ehrenberg R, Hickmann L, et al. Bclx( L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells. World J Gastroenterol. 2008;14:3829-40.
19. Xiang Z, Luo H, Payton JE, Cain J, Ley TJ, Opferman JT, Tomasson MH. Mcl-1 haploinsufficiency protects mice from Myc-induced acute myeloid Leukemia. J Clin Invest. 2010;120: 2109-18.
20. Andersson Y, Juell S. Fodstad. Downregulation of the antiapoptotic MCL-1 protein and apoptosis in MA-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin. Int J Cancer. 2004;112:475-83.
21. Akgul C. Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci. 2009;66:1326-36.
22. Mann CD, Neal CP, Garcea G, et al. Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer. 2007;43:979-92.